Nuveen’s Tevogen Bio Holdings TVGN Stock Holding History

Nuveen’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,805	Closed	-$29.9K	–	3296
2025 Q4	$29.9K	Hold	1,805	–	–	﹤0.01%	3243
2025 Q3	$70.9K	Hold	1,805	–	–	﹤0.01%	3239
2025 Q2	$113K	Hold	1,805	–	–	﹤0.01%	3240
2025 Q1	$97.5K	Buy	+1,805	New	+$119K	﹤0.01%	3216

Other funds holding TVGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Nuveen's TVGN Position: Q1 2026 in Review

Nuveen sold out of Tevogen Bio Holdings (TVGN) in Q1 2026, closing a stake of 1,805 shares — an estimated $29.9K sold.

Nuveen first reported a position in TVGN in Q1 2025 and held it in 4 quarters. The position peaked at $113K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

Nuveen reported no remaining Tevogen Bio Holdings position as of Q1 2026 after selling out during the quarter.
Nuveen sold 1,805 Tevogen Bio Holdings shares in Q1 2026, an estimated $29.9K.
Nuveen first reported a position in Tevogen Bio Holdings in Q1 2025 and held it in 4 quarters.
Nuveen's Tevogen Bio Holdings position peaked at $113K in Q2 2025.
30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.